ErbB4 Genotype Predicts Left Frontotemporal Structural Connectivity in Human Brain

Diminished left frontotemporal connectivity is among the most frequently reported findings in schizophrenia and there is evidence that altered neuronal myelination may in part account for this deficit. Several investigations have suggested that variations of the genes that encode the Neuregulin 1 (NRG1)–ErbB4 receptor complex are associated with schizophrenia illness. As NRG1-–ErbB4 has been implicated in neuronal myelination, we investigated with diffusion tensor imaging (DTI) whether fractional anisotropy (FA)—a putative measure of neuronal myelination—is predicted by a risk haplotype of the ErbB4 gene. The effects of the ErbB4 genotype were investigated in healthy subjects (N=59; mean age: 22.6±1.8 years). We also measured reaction time (RT) during a selective attention/working memory paradigm (visual oddball). In the schizophrenia risk genotype group, we found lower FA in the temporal lobe white matter (WM) including frontotemporal fiber tracts, predominantly in the left hemisphere. RT was increased in the risk genotype group and correlated with FA in the affected brain region. As FA is considered to index structural integrity of WM, to which neuronal fiber myelination is contributing, our results suggest that variations of the ErbB4 genotype may confer risk for schizophrenia illness via its impact on left frontotemporal connectivity in human brain. Reliability and validity of the result is suggested by our observation that (1) the FA–genotype association was not only obtained in the entire sample but also in both the split halves and (2) a statistical relationship was found among RT, genotype and FA.

[1]  Patrick R Hof,et al.  Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia , 2003, Biological Psychiatry.

[2]  R. Straub,et al.  Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls , 2007, Molecular Psychiatry.

[3]  D. Riethmacher,et al.  erbB3 is dispensable for oligodendrocyte development in vitro and in vivo , 2003, Glia.

[4]  Manzar Ashtari,et al.  Clinical and Neuropsychological Correlates of White Matter Abnormalities in Recent Onset Schizophrenia , 2008, Neuropsychopharmacology.

[5]  L. Mei,et al.  Neuregulin 1 in neural development, synaptic plasticity and schizophrenia , 2008, Nature Reviews Neuroscience.

[6]  A. Minkowski,et al.  Regional Development of the Brain in Early Life , 1968 .

[7]  G. Kirov,et al.  Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[8]  Carl-Fredrik Westin,et al.  Fornix Integrity and Hippocampal Volume in Male Schizophrenic Patients , 2006, Biological Psychiatry.

[9]  S. Abe,et al.  The immunoglobulin-like domain is involved in interaction of Neuregulin1 with ErbB. , 2006, Biochemical and biophysical research communications.

[10]  R. Coppola,et al.  Functional and effective frontotemporal connectivity and genetic risk for schizophrenia , 2003, Biological Psychiatry.

[11]  Peter Stoeter,et al.  Association of 5′ end neuregulin-1 (NRG1) gene variation with subcortical medial frontal microstructure in humans , 2008, NeuroImage.

[12]  R. Kahn,et al.  Genes and structural brain imaging in schizophrenia , 2008, Current opinion in psychiatry.

[13]  D Robinson,et al.  Brain-derived neurotrophic factor Val66met polymorphism and volume of the hippocampal formation , 2005, Molecular Psychiatry.

[14]  Udo Rauchfleisch,et al.  5.4 Hamburg-Wechsler Intelligenztest für Erwachsene, Revision 1991 (Tewes, 1994) , 2001 .

[15]  G. Silberberg,et al.  The involvement of ErbB4 with schizophrenia: Association and expression studies , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[16]  S. Wakana,et al.  MRI Atlas of Human White Matter , 2005 .

[17]  M. Munafo,et al.  Neuregulin 1 genotype and schizophrenia. , 2007, Schizophrenia bulletin.

[18]  Daniel R Weinberger,et al.  expression in the brain , 2006 .

[19]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Möller,et al.  Markers from event-related potential subcomponents and reaction time for information processing dysfunction in schizophrenia , 1998, European Archives of Psychiatry and Clinical Neuroscience.

[21]  M Cercignani,et al.  Diffusion tensor magnetic resonance imaging in multiple sclerosis , 2001, Neurology.

[22]  Tobias M. Fischer,et al.  Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain , 2004, Nature Neuroscience.

[23]  Hae-Jeong Park,et al.  Sex differences in the human corpus callosum: diffusion tensor imaging study , 2005, Neuroreport.

[24]  D. Javitt,et al.  Neurophysiological biomarkers for drug development in schizophrenia , 2008, Nature Reviews Drug Discovery.

[25]  A M McIntosh,et al.  The effects of a neuregulin 1 variant on white matter density and integrity , 2008, Molecular Psychiatry.

[26]  E. Bramon,et al.  Selective attention deficits reflect increased genetic vulnerability to schizophrenia , 2008, Schizophrenia Research.

[27]  M. Webster,et al.  Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients , 2008, Schizophrenia Research.

[28]  J. Dubois,et al.  Diffusion tensor imaging of brain development. , 2006, Seminars in fetal & neonatal medicine.

[29]  T. Si,et al.  Chronic antipsychotic drug administration alters the expression of neuregulin 1beta, ErbB2, ErbB3, and ErbB4 in the rat prefrontal cortex and hippocampus. , 2008, The international journal of neuropsychopharmacology.

[30]  Paul J. Harrison,et al.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.

[31]  Alan C. Evans,et al.  Structural maturation of neural pathways in children and adolescents: in vivo study. , 1999, Science.

[32]  Bryan M Hooks,et al.  Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders , 2007, Proceedings of the National Academy of Sciences.

[33]  O. Marín,et al.  Tangential Neuronal Migration Controls Axon Guidance: A Role for Neuregulin-1 in Thalamocortical Axon Navigation , 2006, Cell.

[34]  R. Saunders,et al.  Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain , 2007, Brain Research.

[35]  David Goldman,et al.  Neuroimaging and human genetics. , 2005, International review of neurobiology.

[36]  N. Uranova,et al.  [Morphometric study of ultrastructural changes in oligodendroglial cells in the postmortem brain in endogenous psychoses]. , 2001, Vestnik Rossiiskoi akademii meditsinskikh nauk.

[37]  Philip D. Harvey,et al.  White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.

[38]  Vincent J Schmithorst,et al.  Developmental differences in white matter architecture between boys and girls , 2008, Human brain mapping.

[39]  P Shaw,et al.  Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories , 2007, Molecular Psychiatry.

[40]  L. Mei,et al.  Stimulated ErbB4 internalization is necessary for neuregulin signaling in neurons. , 2007, Biochemical and biophysical research communications.

[41]  T. Kinoshita,et al.  Diffusion Tensor Magnetic Resonance Imaging of Disruption of Regional White Matter in Schizophrenia , 2003, Neuropsychobiology.

[42]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[43]  M. I. Smith,et al.  A study of rotationally invariant and symmetric indices of diffusion anisotropy. , 1999, Magnetic resonance imaging.

[44]  H. Kornblum,et al.  Developmental profile of ErbB receptors in murine central nervous system: Implications for functional interactions , 2005, Journal of neuroscience research.

[45]  B. Turetsky,et al.  Visual attention circuitry in schizophrenia investigated with oddball event-related functional magnetic resonance imaging. , 2007, The American journal of psychiatry.

[46]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[47]  Paul J. Harrison,et al.  Neuregulin 1 and Schizophrenia: Genetics, Gene Expression, and Neurobiology , 2006, Biological Psychiatry.

[48]  Georg Winterer,et al.  Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon? , 2007, Schizophrenia bulletin.

[49]  Daniel Rueckert,et al.  Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.

[50]  Stephan Bender,et al.  Intra-individual reaction time variability in schizophrenia, depression and borderline personality disorder , 2008, Brain and Cognition.

[51]  P. Yakovlev,et al.  The myelogenetic cycles of regional maturation of the brain , 1967 .

[52]  Ramon Casanova,et al.  Biological parametric mapping: A statistical toolbox for multimodality brain image analysis , 2007, NeuroImage.

[53]  J. Salzer,et al.  Type III neuregulin‐1 promotes oligodendrocyte myelination , 2008, Glia.

[54]  G. Corfas,et al.  Presenilin-Dependent ErbB4 Nuclear Signaling Regulates the Timing of Astrogenesis in the Developing Brain , 2006, Cell.

[55]  J. Buxbaum,et al.  Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia , 2004, Nature Neuroscience.

[56]  T. van Amelsvoort,et al.  Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia , 2007, Genes, brain, and behavior.